期刊文献+

人脑胶质瘤相关间充质干细胞的分离、鉴定及生物特性研究 被引量:6

Isolation, identification and biological characteristics of glioblastoma-associated mesenchymal stem cells
原文传递
导出
摘要 目的 从人脑胶质瘤新鲜标本中分离相关间充质干细胞完成鉴定并对其生物特性进行初步研究.方法 将肿瘤组织经过机械法和胰酶消化后经梯度离心法所得的单个细胞悬液使用磁珠分离法筛选CD133阴性细胞进行培养.使用流式细胞术分析表面标志物,使用细胞计数法分析细胞亚群的生长曲线和促肿瘤细胞增殖作用.结果 脑胶质瘤相关间充质干细胞呈贴壁生长,该细胞阳性表达CD73、CD90、CD105,而阴性表达CD14、CD45、CD31,体外诱导条件下可向脂肪细胞和成骨细胞分化,且其条件培养液可促进脑胶质瘤细胞的增殖.结论 胶质瘤相关间充质干细胞存在于脑胶质瘤微环境中,并可能对脑胶质瘤的发展起促进作用. Objective To isolate glioblastoma-associated mesenchymal stem cells (gbMSCs) from fresh human glioblastoma tissues,and investigate the identification and biological characteristics.Methods A cell population was isolated from glioblastoma tissues and was defined as gbMSCs by fluorescence-activated cell sorter (FACS) and differentiation assay.The growth curve and the promotion of gbMSCs were analyzed by cell counting.Results GbMSCs were plastic-adherent cells under standard culture condition;these cells have positive expression of CD105,CD90,CD73,and negative expression of CD14,CD31,CD45; In vitro,mesenchymal stem cells can differentiate into osteocytes,adipocytes under specific stimuli.Moreover,the conditioned medium could promote the proliferation of glioma cells.Conclusion gbMSCs could be found in the tumor microenvironment and may promote the progression of glioblastoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第9期1889-1891,共3页 Chinese Journal of Experimental Surgery
基金 湖北省自然科学基金资助项目(2013CBF126)
关键词 胶质瘤 胶质瘤相关间充质干细胞 分离 鉴定 生物特性 Glioma Glioblastoma-associated mesenchymal stem cells Isolation Identification Biological characteristics
  • 相关文献

参考文献8

  • 1Hanahan D,Weinberg RA.Hallmarks of cancer:the next generation[J].Cell,2011,144 (5):646-674.
  • 2Kang SG,Shinojima N,Hossain A,et al.Isolation and perivascular localization of mesenchymal stem cells from mouse brain[J].Neurosurgery,2010,67(3):711-720.
  • 3Dominici M,Le Blanc K,Mueller I,et al.Minimal criteria for defining multipotent mesenchymal stromal cells.The International Society for Cellular Therapy position statement[J].Cytotherapy,2006,8 (4):315-317.
  • 4Charles NA,Holland EC,Gilbertson R,et al.The brain tumor microenvironment[J].Glia,2012,60 (3):502-514.
  • 5Guo KT,Juerchott K,Fu P,et al.Isolation and characterization of bone marrow-derived progenitor cells from malignant gliomas[J].Anticancer Res,2012,32 (11):4971-4982.
  • 6付朋,姜晓兵,赵洪洋.脑恶性肿瘤患者外周血中髓系衍生抑制细胞的表达[J].中华实验外科杂志,2009,26(5):671-671. 被引量:3
  • 7鞠晓东,娄思权,田华,王卫国,刘延青.脂肪间充质干细胞的基本生物学特性及向成骨细胞诱导分化的实验研究[J].中华实验外科杂志,2004,21(6):654-656. 被引量:50
  • 8Kosztowski T,Zaidi HA,Quinones-Hinojosa A.Applications of neural and mesenchymal stem cells in the treatment of gliomas[J].Expert Rev Anticancer Ther,2009,9(5):597-612.

二级参考文献6

  • 1祝恒成,陈江华,何强,刘修恒,程洪涛.IκBα突变体对树突状细胞成熟及其信号通路的影响[J].中华实验外科杂志,2006,23(12):1574-1574. 被引量:3
  • 2Kusmartsev S, Gabrilovich DI. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother, 2006,55 : 237 -245.
  • 3Dunn GP,Oid LJ,'Schreiber RD,et al. The three ES of cancer immunoediting. Ann Rev Immunol,2004,22:329-360.
  • 4Boris S, David LK, David AB, et al. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. J Neuroimmunol, 2005,169 : 68-85.
  • 5P. Liu,B. O. Oyajobi,R. G. G. Russell,A. Scutt. Regulation of Osteogenic Differentiation of Human Bone Marrow Stromal Cells: Interaction Between Transforming Growth Factor-β and 1,25(OH)2 Vitamin D3 In Vitro[J] 1999,Calcified Tissue International(2):173~180
  • 6赵刚,王春友,王芳,熊炯炘.未成熟树突状细胞在异种移植中的免疫递呈及调节作用[J].中华实验外科杂志,2004,21(4):446-448. 被引量:11

共引文献51

同被引文献30

  • 1许乐,林宗明,朱煜,王国民.过度活化Notch1信号促进肾癌细胞增殖的机制研究[J].肿瘤防治研究,2014,41(2):114-118. 被引量:5
  • 2范存刚,张庆俊.肿瘤坏死因子相关凋亡诱导配体治疗脑胶质瘤的研究进展[J].肿瘤防治研究,2014,41(2):168-172. 被引量:7
  • 3寿雪飞,李士其,张玉林.血管内皮生长因子及其受体表达和侵袭性垂体腺瘤血管生成关系的研究[J].中华神经外科疾病研究杂志,2005,4(5):395-398. 被引量:1
  • 4Savaskan NE, Seufert S, Hauke J, et al. Dissection of mitogenic and ncurodegenerative actions of cystine and glutamate in malignant glio- mas[J]. Oncogenc,2011,30( 1 ) :43-53.
  • 5Nikifomva MN, Hamilton RL. Molecular diagnostics of gliomas [ J ]. Arch Pathol Lab Med,2011,135(5) :558-568.
  • 6Zuniga RM, Torcuator R, Jain R, et al. Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan[ J]. J Neureoncol,2009,91 (3) :329-336.
  • 7Bromberg JE,van den Bent MJ: O!igod, endrogliom ;molecular biology d tfAhhent[ J]. 0ncologist,24(2):155-163.
  • 8Stieber D, GolebiWsk A, vvbs L, et al. Glioblastomas are composed 6f genetically divergent cl0iles with distinct tumourigenic potential and variable stem cell-associated p.hnotypes [ J ]. Acta Neuropathologica 2014,127 (2) :203-219.
  • 9Takebe N,Nguyen D,Yang S X.Targeting Notch signaling pathway in cancer:clinical development advances and challenges[J].Pharmacol Ther,2014,141(2):140-149.
  • 10Turchi L,Debruyne D N,Almairac F,et al.Tumorigenic potential of mi R-18A*in glioma initiating cells requires NOTCH-1 signaling[J].Stem Cells,2013,31(7):1252-1265.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部